# FDA Inspection 1267912 - Wuhan Biocause Pharmaceutical Development Co., Ltd. - March 14, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/wuhan-biocause-pharmaceutical-development-co-ltd/5f5324f9-7060-4d3f-a7d8-749b3776af00
Source feed: FDA_Inspections

> FDA Inspection 1267912 for Wuhan Biocause Pharmaceutical Development Co., Ltd. on March 14, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1267912
- Company Name: Wuhan Biocause Pharmaceutical Development Co., Ltd.
- Inspection Date: 2025-03-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1267912 - 2025-03-14](https://www.globalkeysolutions.net/records/fda_inspections/wuhan-biocause-pharmaceutical-development-co-ltd/cf0802f0-fbd5-4ef6-8a2f-51da576523d8)
- [FDA Inspection 1069379 - 2018-08-24](https://www.globalkeysolutions.net/records/fda_inspections/wuhan-biocause-pharmaceutical-development-co-ltd/58c8650e-e596-4fd1-a0ef-b54e39889c78)
- [FDA Inspection 982641 - 2016-07-22](https://www.globalkeysolutions.net/records/fda_inspections/wuhan-biocause-pharmaceutical-development-co-ltd/8bad144b-a3b7-4ef5-9617-13e620874c65)
- [FDA Inspection 873586 - 2014-02-28](https://www.globalkeysolutions.net/records/fda_inspections/wuhan-biocause-pharmaceutical-development-co-ltd/dd2813e2-7853-4bf3-9edb-2e64132c2ad1)
- [FDA Inspection 680329 - 2010-07-23](https://www.globalkeysolutions.net/records/fda_inspections/wuhan-biocause-pharmaceutical-development-co-ltd/ac25e0ec-0913-49e2-94b5-e1e887e973c7)

Company: https://www.globalkeysolutions.net/companies/wuhan-biocause-pharmaceutical-development-co-ltd/79c352a3-22a2-471e-abbe-1802683656eb

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c